Connect with us

Technology

Oncolytics Biotech® Funds Pelareorep’s Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital

Published

1 year ago

on

SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has entered into a share purchase agreement (SPA) with Alumni Capital LP (Alumni), an institutional investor. This partnership will provide Oncolytics with a flexible source of funding, enabling the Company to progress pelareorep toward key clinical milestones and minimize dilution to create and sustain shareholder value. The SPA allows Oncolytics to be judicious and plan for the timing and amount of any equity sales, which will be critical as pelareorep’s development continues.

Under the terms of the agreement, Oncolytics has the right to sell, and Alumni has the obligation to purchase up to US$20 million worth of common stock over a 15-month period at prices that are based on the market price at the time of each sale to Alumni. Oncolytics, at its sole discretion, controls the timing and amount of all sales of common stock, and there are no warrants, derivatives, or other share classes associated with the SPA. In relation to the execution of the SPA, Oncolytics issued to Alumni 816,326 commitment shares and may issue to Alumni an additional 816,326 commitment shares pro rata upon the delivery of purchase notices under the SPA.

The common shares that may be issued by the Company through the SPA have been conditionally approved for listing on the Toronto Stock Exchange (“TSX”), and the required notices related to the SPA have been filed with the Nasdaq. In obtaining TSX listing approval, the Company has relied on the “Eligible Interlisted Issuer” exemption from TSX rules under section 602.1 of the TSX Company Manual.

No offers or sales of common shares will be made in Canada or through the facilities of the TSX or any other marketplace in Canada.

The common shares under the SPA will be offered and sold to Alumni and may be reoffered and resold by Alumni to the public pursuant to a short form base shelf prospectus (the “Base Shelf Prospectus”) as accompanied by a prospectus supplement (the “Prospectus Supplement”) and pursuant to a prospectus supplement to a base shelf prospectus forming part of the Company’s registration statement on Form F-10 (together with any amendments thereto, the “Registration Statement”) registering the common shares under the United States Securities Act of 1933, as amended, pursuant to the Multi-Jurisdictional Disclosure System adopted by the United States and Canada. The final prospectus supplement has been filed with the securities commissions and other similar regulatory authorities in the province of Alberta and the United States. There will not be any sale of common shares in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws of such province, state or jurisdiction.

Access to the Prospectus Supplement, the Base Shelf Prospectus and any amendments thereto are provided in Canada and the United States in accordance with securities legislation relating to the procedures for providing access to a shelf prospectus supplement, a base shelf prospectus and any amendment to such documents. The Base Shelf Prospectus and the Prospectus Supplement are accessible through SEDAR+ and the Registration Statement, the base shelf prospectus contained therein and the prospectus supplement thereto is accessible through EDGAR at www.sec.gov. An electronic or paper copy of these documents may be obtained, without charge, by contacting the Company at Suite 804, 322 – 11th Avenue SW, Calgary, Alberta T2R 0C5, telephone: (403) 670-7377, email: jpatton@oncolytics.ca. with an email address or mailing address, as applicable. No securities regulatory authority has either approved or disapproved of the contents of this news release.

A copy of the SPA is available in the Company’s Form 6-K that has been filed with the Securities and Exchange Commission.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these common shares in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Oncolytics Biotech Inc.

Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype — turning “cold” tumors “hot” — through innate and adaptive immune responses to treat a variety of cancers.

Pelareorep has demonstrated synergies with multiple approved oncology treatments. Oncolytics is currently conducting and planning combination clinical trials with pelareorep in solid malignancies as it advances towards registrational studies in metastatic breast cancer and pancreatic cancer, both of which have received Fast Track designation from the FDA.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and forward-looking information under applicable Canadian securities laws (such forward-looking statements and forward-looking information are collectively referred to herein as “forward-looking statements”). Forward-looking statements contained in this press release include statements regarding Oncolytics’ belief about the possible sales of common shares, statements regarding how Oncolytics intends to use the proceeds from the sale of common shares, our belief as to the potential, mechanism of action and benefits of pelareorep as a cancer therapeutic; our plans for combination clinical trials with pelareorep in solid malignancies as we advance towards registrational studies in metastatic breast cancer and pancreatic cancer and other statements related to anticipated developments in Oncolytics’ business and technologies. In any forward-looking statement in which Oncolytics expresses an expectation or belief as to future results, such expectations or beliefs are expressed in good faith and are believed to have a reasonable basis, but there can be no assurance that the statement or expectation or belief will be achieved. Such forward-looking statements involve known and unknown risks and uncertainties, which could cause Oncolytics’ actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of pelareorep as a cancer treatment, the success and timely completion of clinical studies and trials, Oncolytics’ ability to successfully commercialize pelareorep, uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. We may incur expenses or delays relating to events outside of our control, which could have a material adverse impact on our business, operating results and financial condition. Investors should consult Oncolytics’ quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake any obligation to update these forward-looking statements, except as required by applicable laws.

Company Contact 
Jon Patton
Director of IR & Communication
jpatton@oncolytics.ca 

Investor Relations for Oncolytics
Mike Moyer
LifeSci Advisors
+1-617-308-4306
mmoyer@lifesciadvisors.com 

Media Contact for Oncolytics
Michael Rubenstein
LifeSci Communications
mrubenstein@lifescicomms.com

Logo – https://mma.prnewswire.com/media/2408622/5262825/Oncolytics_Biotech_Inc_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/oncolytics-biotech-funds-pelareoreps-ongoing-clinical-development-with-a-share-purchase-agreement-in-partnership-with-alumni-capital-302426126.html

SOURCE Oncolytics Biotech® Inc.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

See What 20 Years of Digital Signage Expertise Looks Like, Live at COMPUTEX 2026

Published

45 minutes ago

on

May 4, 2026

By

CAYIN Technology Brings Its Full Enterprise Signage Portfolio to Booth P1202b, Where Real Deployments Begin

TAIPEI, May 4, 2026 /PRNewswire/ — What does enterprise-grade digital signage look like in practice, across retail floors, hospital lobbies, corporate campuses, and transit hubs? At COMPUTEX 2026, CAYIN Technology invites you to find out firsthand. Visit Booth P1202b, Hall 2, 1F, Nangang Exhibition Center, June 2-5, and experience content management platforms and industrial-grade hardware that have been deployed across more than 100 countries worldwide.

Digital Signage Is No Longer Optional. It Is a Business Driver

The most forward-thinking organizations are not just displaying content. They are using digital signage as an active tool for revenue growth, operational efficiency, and brand consistency. The results are measurable:

Retail & F&B: Capture attention at the point of decision with real-time promotions and dynamic menus. Reduce campaign turnaround from days to minutes, and cut recurring print costs entirely.

Corporate & Office: Replace outdated bulletin boards with live announcements, meeting room displays, and wayfinding that adapt to your organization in real time.

Hospitality: Create arrival moments that guests remember, with lobby displays, event schedules, and personalized welcome messages that set your property apart.Healthcare: Ease patient anxiety with clear queue displays, directional guidance, and timely health information. Fewer questions at reception. Smoother patient flow.Transportation & Public Spaces: Keep passengers informed with live schedules, platform changes, and emergency alerts, reducing confusion and improving service perception.
 Education: Connect students, faculty, and visitors to what matters, from campus news and event boards to lecture hall displays and emergency notifications.

Three Solutions, One Trusted Platform, Built for Your Business

CAYIN’s COMPUTEX 2026 lineup addresses the full spectrum of enterprise deployment needs, from high-demand industrial environments to sustainability-driven organizations:

Robustie Solution: Built Tough. Built to Last.
When downtime is not an option, Robustie Solution delivers. Combining industrial-grade CAYIN hardware with CMS-SE, our enterprise content management server, Robustie is engineered for continuous, high-reliability operation across large, multi-site deployments. Centralized management. Consistent performance. No compromises.
 Flexie Solution: Your Infrastructure. Your Control.
Organizations that demand full data sovereignty choose Flexie. Powered by CMS-WS, this self-hosted platform streams content directly from your own hardware to any connected device, browser-based, flexible, and built to meet the most stringent IT security and compliance requirements. Flexie puts you in complete control of your signage network.
 E-Paper Solution: Smarter Signage for a Greener Business.
As ESG commitments move from boardroom pledges to daily operational decisions, E-Paper Solution offers a tangible, measurable path forward. Leveraging e-paper display technology, this ultra-low-power signage platform dramatically reduces energy consumption without sacrificing readability. For organizations serious about reducing their environmental footprint, in retail, logistics, or smart buildings, E-Paper is the signage investment that delivers for your business and your sustainability targets simultaneously.

Your Next Signage Project Starts at Booth P1202b

No two deployments are the same. Whether you are planning your first digital signage rollout, scaling an existing network, or replacing a system that has not delivered, CAYIN’s sales team is at the booth, ready to listen, advise, and map out what integration could look like for your specific environment.

AV system integrators, distributors, resellers, and enterprise IT decision-makers: bring your project brief, your questions, and your challenges. Leave with a clear picture of how CAYIN digital signage fits into your business. Live demonstrations, expert consultations, and real answers, all at Booth P1202b.

Exhibition Details

Event: COMPUTEX 2026
Dates: June 2-5, 2026
Venue: Nangang Exhibition Center, Hall 2, 1F, Taipei
Booth: P1202b

About CAYIN Technology: The Infrastructure Behind the Screen

Behind every screen that never goes dark, there is a platform built to be trusted. CAYIN Technology has been engineering that platform since 2004. Headquartered in Taipei, Taiwan, CAYIN designs and manufactures professional digital signage hardware and software that enterprises in over 100 countries rely on, day in, day out, across retail, hospitality, corporate, healthcare, transportation, and education environments.

Twenty years. One hundred countries. Countless deployments. CAYIN’s track record is not a marketing claim. It is the reason global organizations keep choosing CAYIN as their long-term signage infrastructure partner.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/see-what-20-years-of-digital-signage-expertise-looks-like-live-at-computex-2026-302755482.html

SOURCE CAYIN Technology

Continue Reading

Technology

See What 20 Years of Digital Signage Expertise Looks Like, Live at COMPUTEX 2026

Published

45 minutes ago

on

May 4, 2026

By

CAYIN Technology Brings Its Full Enterprise Signage Portfolio to Booth P1202b, Where Real Deployments Begin

TAIPEI, May 4, 2026 /PRNewswire/ — What does enterprise-grade digital signage look like in practice, across retail floors, hospital lobbies, corporate campuses, and transit hubs? At COMPUTEX 2026, CAYIN Technology invites you to find out firsthand. Visit Booth P1202b, Hall 2, 1F, Nangang Exhibition Center, June 2-5, and experience content management platforms and industrial-grade hardware that have been deployed across more than 100 countries worldwide.

Digital Signage Is No Longer Optional. It Is a Business Driver

The most forward-thinking organizations are not just displaying content. They are using digital signage as an active tool for revenue growth, operational efficiency, and brand consistency. The results are measurable:

Retail & F&B: Capture attention at the point of decision with real-time promotions and dynamic menus. Reduce campaign turnaround from days to minutes, and cut recurring print costs entirely.

Corporate & Office: Replace outdated bulletin boards with live announcements, meeting room displays, and wayfinding that adapt to your organization in real time.

Hospitality: Create arrival moments that guests remember, with lobby displays, event schedules, and personalized welcome messages that set your property apart.Healthcare: Ease patient anxiety with clear queue displays, directional guidance, and timely health information. Fewer questions at reception. Smoother patient flow.Transportation & Public Spaces: Keep passengers informed with live schedules, platform changes, and emergency alerts, reducing confusion and improving service perception.
 Education: Connect students, faculty, and visitors to what matters, from campus news and event boards to lecture hall displays and emergency notifications.

Three Solutions, One Trusted Platform, Built for Your Business

CAYIN’s COMPUTEX 2026 lineup addresses the full spectrum of enterprise deployment needs, from high-demand industrial environments to sustainability-driven organizations:

Robustie Solution: Built Tough. Built to Last.
When downtime is not an option, Robustie Solution delivers. Combining industrial-grade CAYIN hardware with CMS-SE, our enterprise content management server, Robustie is engineered for continuous, high-reliability operation across large, multi-site deployments. Centralized management. Consistent performance. No compromises.
 Flexie Solution: Your Infrastructure. Your Control.
Organizations that demand full data sovereignty choose Flexie. Powered by CMS-WS, this self-hosted platform streams content directly from your own hardware to any connected device, browser-based, flexible, and built to meet the most stringent IT security and compliance requirements. Flexie puts you in complete control of your signage network.
 E-Paper Solution: Smarter Signage for a Greener Business.
As ESG commitments move from boardroom pledges to daily operational decisions, E-Paper Solution offers a tangible, measurable path forward. Leveraging e-paper display technology, this ultra-low-power signage platform dramatically reduces energy consumption without sacrificing readability. For organizations serious about reducing their environmental footprint, in retail, logistics, or smart buildings, E-Paper is the signage investment that delivers for your business and your sustainability targets simultaneously.

Your Next Signage Project Starts at Booth P1202b

No two deployments are the same. Whether you are planning your first digital signage rollout, scaling an existing network, or replacing a system that has not delivered, CAYIN’s sales team is at the booth, ready to listen, advise, and map out what integration could look like for your specific environment.

AV system integrators, distributors, resellers, and enterprise IT decision-makers: bring your project brief, your questions, and your challenges. Leave with a clear picture of how CAYIN digital signage fits into your business. Live demonstrations, expert consultations, and real answers, all at Booth P1202b.

Exhibition Details

Event: COMPUTEX 2026
Dates: June 2-5, 2026
Venue: Nangang Exhibition Center, Hall 2, 1F, Taipei
Booth: P1202b

About CAYIN Technology: The Infrastructure Behind the Screen

Behind every screen that never goes dark, there is a platform built to be trusted. CAYIN Technology has been engineering that platform since 2004. Headquartered in Taipei, Taiwan, CAYIN designs and manufactures professional digital signage hardware and software that enterprises in over 100 countries rely on, day in, day out, across retail, hospitality, corporate, healthcare, transportation, and education environments.

Twenty years. One hundred countries. Countless deployments. CAYIN’s track record is not a marketing claim. It is the reason global organizations keep choosing CAYIN as their long-term signage infrastructure partner.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/see-what-20-years-of-digital-signage-expertise-looks-like-live-at-computex-2026-302755482.html

SOURCE CAYIN Technology

Continue Reading

Technology

Weixin Brand Protection Report Marks a Decade of Partnership, Trust, and Progress in IP Protection

Published

45 minutes ago

on

May 4, 2026

By

Defending 700+ global brands across 30+ industries & 20+ regions

Scalable, User‑driven and AI‑powered Enforcement
Transforms IP defense from Reactive Takedowns to Sustained Proactive Prevention.

LONDON, May 4, 2026 /PRNewswire/ — Tencent today released its 2025 Weixin Brand Protection Report, marking a decade of progress in intellectual property (IP) protection on Weixin. The report shows how Weixin’s Brand Protection Platform (BPP), through close collaboration with brands, community participation, and AI-driven detection, has helped shift enforcement from reactive takedowns to sustained proactive prevention.

Key Highlights in 2025

Metric

Results

Livestream rooms proactively shut down

5.7× more

Enforcement value recovered

$430 million+

Brands on the BPP

700+ across 30+ industries & 20+ regions

New publishing partners on the BPP

14

Suspicious product listings blocked

232,000

Suspicious store applications removed

14,000

Infringing listings taken down

728,000+

Infringing stores penalized

9,000+

A Decade of Global Partnership, Trust, and Progress

For ten years, Weixin has supported brand integrity and advanced IP protection by embedding enforcement directly within its platform to rapidly detect and stop infringement, particularly in fast-growing areas like short-form video and livestream commerce.

“Weixin has built a truly collaborative IP‑protection ecosystem that unites authorities, brands, and users to deliver the next generation of enforcement,” said Danny Marti, Head of Global Public Policy at Tencent. “By leveraging AI, real‑time user reports, advanced analytics, and close partnership with brands and regulators, we’re creating a trusted environment that lets global brands confidently engage with consumers.”

Weixin’s approach connects online detection with offline enforcement, translating digital intelligence into real-world action against counterfeiters. In 2025, the BPP helped authorities pursue 37 cases involving more than 300 suspects and totaling over $430 million in value.

Since 2021 the BPP has grown by more than 50 %. Today it hosts more than 700 brands across 30+ industries and 20+ countries and regions. In the past year, the BPP welcomed 62 new members including several from newly added categories, most notably publishing, which saw the addition of 14 publishers since October 2025.

Additionally, the Weixin IP Protection Alliance was launched in 2025 to co‑develop tools, share intelligence, and deepen brand partnerships. This ecosystem approach, combining technology, users, and brand collaboration, positions Weixin as a model for protecting IP while enabling growth in global and digital markets.

“At PUMA, protecting intellectual property is an important component of maintaining brand integrity and supporting sustainable growth,” said Wei Zhang, Senior Counsel, Brand Protection at PUMA. “Tools such as the BPP contribute to enforcement efforts across digital channels and, in practice, support broader brand protection strategies spanning both online and offline environments.”

User Mobilization at Scale

A key driver of this system is the role users continue to play in helping identify suspected infringement. More than 95% of takedown notices and reports against suspicious personal accounts came from users. Over 99% of reports on suspicious group-chat activity were submitted by users, and more than 96% of infringing accounts were discovered by users.

AI Powers Proactive Prevention

In December 2025, Weixin introduced “Mini-WA,” an AI-powered assistant that delivers real-time support and actionable insights to help brands navigate the platform and improve IP governance. As digital ecosystems grow more complex, Mini-WA empowers brands with intuitive, consistent and proactive guidance, enhancing usability and early detection of potential risks.

With the rise of digital commerce and short‑form content, the BPP demonstrates a proven model for integrated IP protection and significant progress to empower brands, safeguard consumers, and foster trust online and offline.

To view the full Weixin Brand Protection Platform Report, please visit: https://static.www.tencent.com/attachments/reports/Tencent-BPP-Report-2025.pdf

For media inquiries, contact:

gc@tencent.com

View original content:https://www.prnewswire.com/news-releases/weixin-brand-protection-report-marks-a-decade-of-partnership-trust-and-progress-in-ip-protection-302759637.html

SOURCE Tencent

Continue Reading

Trending